switch to a hydrophilic statin (rosuvastatin, pravastatin) if myalgias localize SGLT2 inhibitors: reinforce hydration targets (minimum 2.5 L daily) Laxatives or stimulant bowel preps: reduce frequency if already experiencing GLP-1-related diarrhea Tier 3: Low risk but worth documenting ACE inhibitors (can rarely cause cramps through unclear mechanisms) Beta-agonist inhalers (albuterol can lower serum potassium at high doses) The Endocrine Society's 2023 clinical practice guideline on pharmacologic management of obesity recommends monitoring electrolytes during the titration phase of anti-obesity medications, with particular attention to patients on concurrent diuretic therapy 9
The change in GLP-1 response was statistically significant at the 3-gram dose but not at the 1-gram dose
Resuming at maximum dose risks severe nausea, vomiting, and dehydration
I will always recommend this office and Dr Zubair to friends and family
[1] In clinical trials, the most frequently reported adverse effects of Zepbound were gastrointestinal in nature, including nausea, diarrhea, vomiting, constipation, and abdominal pain
The core chelation site relies on the imidazole ring of histidine and the side chain amino group of lysine to ensure the controlled release of copper ions